Cargando…

Timosaponin AIII Inhibits Migration and Invasion Abilities in Human Cervical Cancer Cells through Inactivation of p38 MAPK-Mediated uPA Expression In Vitro and In Vivo

SIMPLE SUMMARY: Cervical cancer is one of the most common cancers in women. High resistance to chemotherapeutic agents and adaptation to radiotherapy in cervical cancer patients can lead to severe mortality. The aim of our study was to assess Timosaponin AIII (TSAIII) as a novel therapeutic approach...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chien, Hung-Ju, Liu, Chung-Jung, Ying, Tsung-Ho, Wu, Pei-Ju, Wang, Jiunn-Wei, Ting, Yi-Hsuan, Hsieh, Yi-Hsien, Wang, Shih-Chiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817900/ https://www.ncbi.nlm.nih.gov/pubmed/36612038 http://dx.doi.org/10.3390/cancers15010037

Ejemplares similares

Blockage of Autophagy Increases Timosaponin AIII-Induced Apoptosis of Glioma Cells In Vitro and In Vivo
por: Lee, Chu-Che, et al.
Publicado: (2022)

The Potential Role of Timosaponin-AIII in Cancer Prevention and Treatment
por: Liu, Zhaowen, et al.
Publicado: (2023)

Antiangiogenesis effect of timosaponin AIII on HUVECs in vitro and zebrafish embryos in vivo
por: Zhou, Zhong-yan, et al.
Publicado: (2019)

Antibody-modified liposomes for tumor-targeting delivery of timosaponin AIII
por: Lu, Lu, et al.
Publicado: (2018)

Timosaponin AIII Induces G2/M Arrest and Apoptosis in Breast Cancer by Activating the ATM/Chk2 and p38 MAPK Signaling Pathways
por: Zhang, Minjie, et al.
Publicado: (2021)

Potential Antimetastatic Effect of Timosaponin AIII against Human Osteosarcoma Cells through Regulating the Integrin/FAK/Cofilin Axis
por: Hsieh, Yi-Hsien, et al.
Publicado: (2021)

Comparison of the pharmacokinetics of timosaponin AIII, timosaponin BIII, and mangiferin extracted from crude and salt-processed Anemarrhenae Rhizoma by UPLC-MS/MS
por: Wang, XiaoTing, et al.
Publicado: (2023)

High expression of uPA related to p38MAPK in esophageal cancer indicates poor prognosis
por: Liu, Qilong, et al.
Publicado: (2018)

Synergistic anticancer effects of timosaponin AIII and ginsenosides in MG63 human osteosarcoma cells
por: Jung, Okkeun, et al.
Publicado: (2019)

TEM8 functions as a receptor for uPA and mediates uPA-stimulated EGFR phosphorylation
por: Zhang, Lian-Cheng, et al.
Publicado: (2018)

Timosaponin AIII inhibits melanoma cell migration by suppressing COX‐2 and in vivo tumor metastasis
por: Kim, Ki Mo, et al.
Publicado: (2016)

Timosaponin AIII Is Preferentially Cytotoxic to Tumor Cells through Inhibition of mTOR and Induction of ER Stress
por: King, Frank W., et al.
Publicado: (2009)

Rapid and Sensitive Determination of Timosaponin AIII in Rat Plasma by LC-MS/MS and Its Pharmacokinetic Application
por: Liu, Yanping, et al.
Publicado: (2013)

Ginsenoside Rg1 Drives Stimulations of Timosaponin AIII-Induced Anticancer Effects in Human Osteosarcoma Cells
por: Lee, Sang Yeol
Publicado: (2020)

Timosaponin AIII Suppresses RAP1 Signaling Pathway to Enhance the Inhibitory Effect of Paclitaxel on Nasopharyngeal Carcinoma
por: Li, Xiaofeng, et al.
Publicado: (2022)

Timosaponin AIII induces antiplatelet and antithrombotic activity via Gq-mediated signaling by the thromboxane A2 receptor
por: Cong, Yue, et al.
Publicado: (2016)

Novel Timosaponin AIII-Based Multifunctional Liposomal Delivery System for Synergistic Therapy Against Hepatocellular Carcinoma Cancer
por: Zhang, Lijuan, et al.
Publicado: (2021)

Retracted: Timosaponin AIII Suppresses RAP1 Signaling Pathway to Enhance the Inhibitory Effect of Paclitaxel on Nasopharyngeal Carcinoma
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Pharmacological Activity, Pharmacokinetics, and Toxicity of Timosaponin AIII, a Natural Product Isolated From Anemarrhena asphodeloides Bunge: A Review
por: Lin, Yan, et al.
Publicado: (2020)

Functional Axis of PDE5/cGMP Mediates Timosaponin-AIII-Elicited Growth Suppression of Glioblastoma U87MG Cells
por: Liao, Ya-Fang, et al.
Publicado: (2023)

Anemarrhena asphodeloides Bunge and its constituent timosaponin‐AIII induce cell cycle arrest and apoptosis in pancreatic cancer cells
por: MarElia, Catherine B., et al.
Publicado: (2018)

Independent validation of stromal uPA in ABCSG-08: Level 1b evidence for the prognostic value of uPA immunohistochemistry
por: Singer, C.F., et al.
Publicado: (2022)

The uPA System Differentially Alters Fibroblast Fate and Profibrotic Ability in Skin Fibrosis
por: Zou, Ming-Li, et al.
Publicado: (2022)

Construction of a Single Lentiviral Vector Containing Tetracycline-Inducible Alb-uPA for Transduction of uPA Expression in Murine Hepatocytes
por: Bai, Jiasi, et al.
Publicado: (2013)

Timosaponin AIII Suppresses Hepatocyte Growth Factor-Induced Invasive Activity through Sustained ERK Activation in Breast Cancer MDA-MB-231 Cells
por: Tsai, Chung-Hsin, et al.
Publicado: (2013)

uPA-mediated plasminogen activation is enhanced by polyphosphate
por: Whyte, Claire S., et al.
Publicado: (2020)

Snail mediates invasion through uPA/uPAR and the MAPK signaling pathway in prostate cancer cells
por: RANDLE, DIANDRA D., et al.
Publicado: (2013)

The uPA/uPAR system in astrocytic wound healing
por: Yepes, Manuel
Publicado: (2022)

Expression of uPA, tPA, and PAI-1 in Calcified Aortic Valves
por: Kochtebane, Najlah, et al.
Publicado: (2014)

uPA deficiency exacerbates muscular dystrophy in MDX mice
por: Suelves, Mònica, et al.
Publicado: (2007)

uPA deficiency exacerbates muscular dystrophy in MDX mice
por: Suelves, Mònica, et al.
Publicado: (2007)

Inhibitory effect of isomorellin on cholangiocarcinoma cells via suppression of NF-κB translocation, the phosphorylated p38 MAPK pathway and MMP-2 and uPA expression
por: Hahnvajanawong, Chariya, et al.
Publicado: (2021)

Timosaponin AIII promotes non-small-cell lung cancer ferroptosis through targeting and facilitating HSP90 mediated GPX4 ubiquitination and degradation
por: Zhou, Cong, et al.
Publicado: (2023)

COVID-19 and pneumonia: a role for the uPA/uPAR system
por: D’Alonzo, Daniele, et al.
Publicado: (2020)

Clinical significance of the uPA system in gastric cancer with peritoneal metastasis
por: Ding, Youcheng, et al.
Publicado: (2013)

uPA dependent and independent mechanisms of wound healing by C-phycocyanin
por: Madhyastha, H K, et al.
Publicado: (2008)

Inhibition of Human Urokinase-Type Plasminogen Activator (uPA) Enzyme Activity and Receptor Binding by DNA Aptamers as Potential Therapeutics through Binding to the Different Forms of uPA
por: Dreymann, Nico, et al.
Publicado: (2022)

Poised Transcription Factories Prime Silent uPA Gene Prior to Activation
por: Ferrai, Carmelo, et al.
Publicado: (2010)

The autoactivation of human single-chain urokinase-type plasminogen activator (uPA)
por: Torres-Paris, Constanza, et al.
Publicado: (2023)

Effects of ulinastatin and docetaxel on breast cancer invasion and expression of uPA, uPAR and ERK
por: Luo, Jie, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_qhgc5q4j8p2e2offktbusgo7vv